Post‑Transplant, Herpesvirus 6 DNA, Real‑Time PCR, Plasma
Also known as: PTxplnt, Specialized, Human Herpes Virus, Txplnt, Services
Use
This test is used to determine the presence of HHV‑6 DNA in patients’ plasma specimens. PCR may detect organisms earlier than immunological methods and provides more rapid results than culture methods. Reportable range is approximately 500 to 2,000,000 copies/mL (2.70 to 6.30 log copies/mL).
Special Instructions
Not provided.
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed, and its performance characteristics determined by Med Fusion (Quest Diagnostics). It has not been cleared or approved by the U.S. Food and Drug Administration (FDA), but the FDA has determined that such clearance or approval is not necessary. This laboratory is certified under CLIA as qualified to perform high complexity clinical laboratory testing.
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
EDTA (lavender‑top) tube
Storage Instructions
Refrigerated
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |